<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Canadian Pharmacy Blog</title>
	<atom:link href="http://www.canadiannetmall.com/blog/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.canadiannetmall.com/blog</link>
	<description></description>
	<lastBuildDate>Sat, 07 May 2011 13:51:31 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
		<item>
		<title>High-Risk Patients and High-Dose Intravenous Immune Globulin</title>
		<link>http://www.canadiannetmall.com/blog/high-risk-patients-and-high-dose-intravenous-immune-globulin/</link>
		<comments>http://www.canadiannetmall.com/blog/high-risk-patients-and-high-dose-intravenous-immune-globulin/#comments</comments>
		<pubDate>Sat, 07 May 2011 13:51:31 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Drugs News]]></category>
		<category><![CDATA[High-Dose Intravenous]]></category>
		<category><![CDATA[Immune Globulin]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=4656</guid>
		<description><![CDATA[Caution is imperative when high doses of intravenous immune globulin (IVIg) treatment are given to obese patients and to patients with risk factors for thrombosis, say researchers who reported on two cases of thrombotic complications. One patient, with idiopathic thrombo-cytopenic purpura, received 1 g/kg of IVIg per day as a five-hour infusion daily for two [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/high-risk-patients-and-high-dose-intravenous-immune-globulin/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Coxibs Can Go It Alone</title>
		<link>http://www.canadiannetmall.com/blog/coxibs-can-go-it-alone/</link>
		<comments>http://www.canadiannetmall.com/blog/coxibs-can-go-it-alone/#comments</comments>
		<pubDate>Fri, 06 May 2011 13:51:30 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Pain medicine]]></category>
		<category><![CDATA[Coxibs]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=4658</guid>
		<description><![CDATA[Although cyclooxygenase 2 (COX-2) inhibitors, also called &#8220;coxibs,&#8221; can be easier on the gastrointestinal system than nonsteroidal anti-inflammatory drugs (NSAIDs are, some physicians prefer to err on the side of caution by prescribing a gastroprotective agent (GPA) as well. The coxibs were named after two recently developed anti-inflammatory drugs, canadian celecoxib (Celebrex drug, Pharmacia) and [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/coxibs-can-go-it-alone/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>&#8220;Five-in-One&#8221; Vaccine Means Fewer Injections</title>
		<link>http://www.canadiannetmall.com/blog/five-in-one-vaccine-means-fewer-injections/</link>
		<comments>http://www.canadiannetmall.com/blog/five-in-one-vaccine-means-fewer-injections/#comments</comments>
		<pubDate>Thu, 05 May 2011 13:51:28 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Drugs News]]></category>
		<category><![CDATA[Fewer Injections]]></category>
		<category><![CDATA[Vaccine]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=4660</guid>
		<description><![CDATA[A new vaccine, which is expected to be able to eliminate six of the 20 injections that babies receive before age two years, has received federal approval. Pediarix™ (GlaxoSmithKline) combines protection, into one injection, against five serious diseases—diphtheria, tetanus, whooping cough (pertussis), hepatitis B, and polio. The vaccine is to be given in a three-dose [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/five-in-one-vaccine-means-fewer-injections/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Asthma Drug Approved for Hay Fever</title>
		<link>http://www.canadiannetmall.com/blog/asthma-drug-approved-for-hay-fever/</link>
		<comments>http://www.canadiannetmall.com/blog/asthma-drug-approved-for-hay-fever/#comments</comments>
		<pubDate>Wed, 04 May 2011 13:51:28 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Asthma]]></category>
		<category><![CDATA[Asthma Drug]]></category>
		<category><![CDATA[Hay Fever]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=4662</guid>
		<description><![CDATA[Montelukast sodium (Singulair canadian, Merck), currently on the market for asthma control, has now been approved for the relief of symptoms of hay fever, also known as seasonal allergic rhinitis. The once-a-day tablet can help to relieve a broad array of allergy symptoms for 24 hours and can be used to treat adults and children [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/asthma-drug-approved-for-hay-fever/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Risky Glaucoma Treatment</title>
		<link>http://www.canadiannetmall.com/blog/risky-glaucoma-treatment/</link>
		<comments>http://www.canadiannetmall.com/blog/risky-glaucoma-treatment/#comments</comments>
		<pubDate>Tue, 03 May 2011 13:51:28 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Drugs News]]></category>
		<category><![CDATA[glaucoma treatment]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=4664</guid>
		<description><![CDATA[Older patients who are treated with topical beta blockers for glaucoma, a major cause of blindness, may be at a higher risk of airways obstruction—even if they have no history of respiratory disease, say researchers from the Institute of Ophthalmology, Royal Brompton Hospital, and Moorfields Eye Hospital, all in London. Analyzing data from 11,739 patients, [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/risky-glaucoma-treatment/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>REACH Award Announced</title>
		<link>http://www.canadiannetmall.com/blog/reach-award-announced/</link>
		<comments>http://www.canadiannetmall.com/blog/reach-award-announced/#comments</comments>
		<pubDate>Mon, 02 May 2011 13:51:23 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Drugs News]]></category>
		<category><![CDATA[REACH]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=4666</guid>
		<description><![CDATA[Sanofi-Synthelabo and Bristol-Myers Squibb have announced the launch of the REACH (deduction of Atherothrom-bosis for Continued Health) Award Program, which aims to recognize promising work in improving the management of this disease. canadian cialis online Random Posts:Longer Life For Drug-Coated StentLung Cancer Survival in Men and WomenGenotyping Test Screens For Drug EffectivenessUSP Drug-Quality ProgramExtavia for Relapsing [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/reach-award-announced/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Combination Interferon For Chronic Hepatitis C Virus</title>
		<link>http://www.canadiannetmall.com/blog/combination-interferon-for-chronic-hepatitis-c-virus/</link>
		<comments>http://www.canadiannetmall.com/blog/combination-interferon-for-chronic-hepatitis-c-virus/#comments</comments>
		<pubDate>Sun, 01 May 2011 13:51:22 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Anti Viral]]></category>
		<category><![CDATA[Combination Interferon]]></category>
		<category><![CDATA[Hepatitis C]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=4668</guid>
		<description><![CDATA[Pegylated interferon (peg-interferon) alfa-2a (Pegasys®, Roche), combined with ribavirin (Rebetol tablet, Schering), is now available for the treatment of patients with chronic hepatitis C virus (HCV). This combination is intended for adults with compensated liver disease and who have not previously taken alpha interferons. (Please see the December 2002 issue of P&#38;T for a review [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/combination-interferon-for-chronic-hepatitis-c-virus/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

